Hiroshi Nishihara
Papers
2
Total Citations
8
H-Index
2
About
Dr. Hiroshi Nishihara is a prominent cancer genomics researcher whose work centers on the molecular mechanisms driving urological malignancies, particularly clear cell renal cell carcinoma (ccRCC) and prostate cancer. His major contributions include elucidating how specific chromosomal rearrangements, such as derivative chromosome 3 loss from t(3;6)(q12;q14), cooperate with differential VHL gene mutations to drive multifocal ccRCC tumorigenesis. This research provides critical insights into the clonal evolution and heterogeneity of kidney cancer, demonstrating how distinct genetic events in separate tumor foci can arise from a common ancestral lesion. Dr. Nishihara’s work has also explored the clinical significance of tumor suppressor gene co-loss, as evidenced by his case study of a Japanese patient with organ-confined prostate cancer harboring concurrent BRCA2 and RB1 loss, successfully treated by radical prostatectomy. Though early in its citation impact, his research is foundational for understanding the interplay between structural genomic alterations and point mutations in cancer development. Dr. Nishihara’s findings have direct implications for personalized risk stratification and targeted therapy strategies in urologic oncology, positioning him as an emerging authority in the field of cancer genetics.
Research Focus
Key Achievements
Top Papers
- 1
- 2